SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-002484
Filing Date
2018-01-17
Accepted
2018-01-17 07:15:35
Documents
3
Period of Report
2018-01-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-3340_18k.htm 8-K 44935
2 EX-99.1 a18-3340_1ex99d1.htm EX-99.1 25402
3 GRAPHIC g33401moi001.jpg GRAPHIC 3301
  Complete submission text file 0001104659-18-002484.txt   76247
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 8-K | Act: 34 | File No.: 001-37569 | Film No.: 18529758
SIC: 2834 Pharmaceutical Preparations